The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple- negative breast cancer
Adam T. Nelczyk, Liqian Ma, Anasuya Das Gupta, Hashni Epa Vidana Gamage, Michael T. McHenry, Madeline Henn, Mohammed Kadiri, Yu Wang, Natalia Krawczyńska, Shruti V. Bendre, Sisi He, Sayyed Hamed Shahoei, Zeynep Madak‐Erdogan, Shih‐Hsuan Hsiao, Tareq Saleh, Valerie J. Carpenter, David A. Gewirtz, Michael J. Spinella, Erik R. Nelson
Topics & Concepts
Triple-negative breast cancerCancer researchBreast cancerEstrogen receptorNuclear receptorCancerBiologyEstrogen receptor alphaProgesterone receptorCell growthReceptorOncologyInternal medicineMedicineGeneTranscription factorGeneticsLung Cancer Treatments and MutationsEstrogen and related hormone effectsHER2/EGFR in Cancer Research